The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development
Open accessAbstract
Glucose is a key metabolite used by cancer cells to generate ATP, maintain redox state and create biomass. Glucose can be catabolized to lactate in the cytoplasm, which is termed glycolysis or alternatively can be catabolized to carbon dioxide and water in the mitochondria via oxidative phosphorylation (OXPHOS). Metabolic heterogeneity exists in a subset of human tumors, with some cells maintaining a glycolytic phenotype while others predominantly utilize OXPHOS. Cells within tumors interact metabolically with transfer of catabolites from supporting stromal cells to adjacent cancer cells. The Reverse Warburg Effect describes when glycolysis in the cancer-associated stroma metabolically supports adjacent cancer cells. This catabolite transfer, which induces stromal-cancer metabolic coupling, allows cancer cells to generate ATP, increase proliferation and reduce cell death. Catabolites implicated in metabolic coupling include the monocarboxylates lactate, pyruvate and ketone bodies. Monocarboxylate transporters (MCT) are critically necessary for release and uptake of these catabolites. MCT4 is involved in the release of monocarboxylates from cells, is regulated by catabolic transcription factors such as hypoxia inducible factor 1 alpha (HIF1A) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and is highly expressed in cancer-associated fibroblasts. Conversely, MCT1 is predominantly involved in the uptake of these catabolites and is highly expressed in a subgroup of cancer cells. MYC and TIGAR, which are genes involved in cellular proliferation and anabolism are inducers of MCT1. Profiling human tumors on the basis of an altered redox balance and intra-tumoral metabolic interactions may have important biomarker and therapeutic implications. Alterations in the redox state and mitochondrial function of cells can induce metabolic coupling. Hence, there is interest in redox and metabolic modulators as anticancer agents. Also, markers of metabolic coupling have been associated with poor outcomes in numerous human malignancies and may be useful prognostic and predictive biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601 · cited 1×
“It has been well described that activation of HIF1A causes autophagy [55] [56].”
BackgroundRetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Glutathione Metabolism and Its Implications for Health
Wu, G., Lupton, J. R., Turner, N. D., Fang, Y.-Z., & Yang, S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.3.489 · Cited by 3,842
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 1×
“Similar findings with metabolic coupling between stromal and cancer cells involving lactate, pyruvate, beta-hydroxybutyrate, acetate, fatty acids, glutamine and alanine have been discovered in many human malignancies including breast, ovarian, prostate, liver, colon, pancreatic and head and neck squamous cell cancer (…”
ResultFundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · cited 2×
“Despite evidence that the majority of cancer cell mitochondria are not dysfunctional and that many different tumor metabolic profiles exist, this theory, known as the “Warburg Effect,” has been a prevailing theory of tumor metabolism [9] [10] [11].”
BackgroundWallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 1×
“The antidiabetic drug metformin is known to alter cellular metabolism through mitochondrial OXPHOS complex I inhibition [76] [77] [78] [79] [80].”
BackgroundTIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 10×
“Gerin I, et al. Identification of TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase.”
BackgroundInfluentialMitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 1×
“Both NO and ROS can induce HIF1A, in an oxygen independent and dependent fashion, respectively, leading to enhanced glycolysis [53] [60] [61].”
BackgroundMitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742 · cited 2×
“Despite evidence that the majority of cancer cell mitochondria are not dysfunctional and that many different tumor metabolic profiles exist, this theory, known as the “Warburg Effect,” has been a prevailing theory of tumor metabolism [9] [10] [11].”
BackgroundTargeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., De Saedeleer, C. J., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,624
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Self-citationBellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouysségur, J., & Mazure, N. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-09 · Cited by 1,501
Metabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,462
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391
Self-citationBirsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., & Sabatini, D. M. (2015) · Cell · doi:10.1016/j.cell.2015.07.016 · Cited by 1,388
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259
Targeting lactate metabolism for cancer therapeutics
Doherty, J. R., & Cleveland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69741 · Cited by 1,166
Metabolic heterogeneity in human lung tumors
Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.034 · Cited by 1,138
Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
Sousa, C. M., Biancur, D. E., Wang, X., Halbrook, C. J., Sherman, M. H., Zhang, L., Kremer, D., Hwang, R. F., Witkiewicz, A. K., Ying, H., et al. (2016) · Nature · doi:10.1038/nature19084 · Cited by 1,122
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105 · cited 1×
“The antidiabetic drug metformin is known to alter cellular metabolism through mitochondrial OXPHOS complex I inhibition [76] [77] [78] [79] [80].”
BackgroundUllah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 890
Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
DeBerardinis, R. J., & Thompson, C. B. (2012) · Cell · doi:10.1016/j.cell.2012.02.032 · Cited by 858
Dissecting the Interaction between Nitric Oxide Synthase (NOS) and Caveolin
Garcı́a-Cardeña, G., Martasek, P., Masters, B. S. S., Skidd, P. M., Couet, J., Li, S., Lisanti, M. P., & Sessa, W. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25437 · Cited by 821
Schug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S., Goodwin, L. M., Smethurst, E., Mason, S., Blyth, K., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.002 · Cited by 820 · cited 1×
“Similar findings with metabolic coupling between stromal and cancer cells involving lactate, pyruvate, beta-hydroxybutyrate, acetate, fatty acids, glutamine and alanine have been discovered in many human malignancies including breast, ovarian, prostate, liver, colon, pancreatic and head and neck squamous cell cancer (…”
ResultInhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Škrtić, M., Sriskanthadevan, S., Jhas, B., Gebbia, M., Wang, X., Wang, Z., Hurren, R., Jitkova, Y., Gronda, M., Maclean, N., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.015 · Cited by 678
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V. R., da Costa, A. S. H., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M. G. B., et al. (2016) · Nature · doi:10.1038/nature19353 · Cited by 584
Fiaschi, T., Marini, A., Giannoni, E., Taddei, M. L., Gandellini, P., De Donatis, A., Lanciotti, M., Serni, S., Cirri, P., & Chiarugi, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1949 · Cited by 578
Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X.-L., Rajagopalan, K. N., Maddie, M., Vemireddy, V., Zhao, Z., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.001 · Cited by 529
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Caro, P., Kishan, A. U., Norberg, E., Stanley, I. A., Chapuy, B., Ficarro, S. B., Polak, K., Tondera, D., Gounarides, J., Yin, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.014 · Cited by 528
Roles of p53, MYC and HIF-1 in regulating glycolysis–the seventh hallmark of cancer
Yeung, S. J., Pan, J., & Lee, M.-H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8224-x · Cited by 514
Martinez-Outschoorn, U. E., Balliet, R. M., Rivadeneira, D., Chiavarina, B., Pavlides, S., Wang, C., Whitaker-Menezes, D., Daumer, K., Lin, Z., Witkiewicz, A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12553 · Cited by 460
Self-citationKoukourakis, M. I., Giatromanolaki, A., Harris, A. L., & Sivridis, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3260 · Cited by 440
Yang, L., Achreja, A., Yeung, T.-L., Mangala, L. S., Jiang, D., Han, C., Baddour, J., Marini, J. C., Ni, J., Nakahara, R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.011 · Cited by 429
Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Lin, Z., Ertel, A., Flomenberg, N., Witkiewicz, A. K., Birbe, R., Howell, A., Pavlides, S., Gandara, R., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15659 · Cited by 409
Self-citationMartinez-Outschoorn, U. E., Trimmer, C., Lin, Z., Whitaker-Menezes, D., Chiavarina, B., Zhou, J., Wang, C., Pavlides, S., Martinez-Cantarin, M. P., Capozza, F., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12928 · Cited by 408
Self-citationDoherty, J. R., Yang, C., Scott, K. E. N., Cameron, M. D., Fallahi, M., Li, W., Hall, M. A., Amelio, A. L., Mishra, J. K., Li, F., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2034 · Cited by 400
Mitochondria as biosynthetic factories for cancer proliferation
Ahn, C. S., & Metallo, C. M. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0128-2 · Cited by 399
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Polański, R., Hodgkinson, C. L., Fusi, A., Nonaka, D., Priest, L., Kelly, P., Trapani, F., Bishop, P. W., White, A., Critchlow, S. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2270 · Cited by 378
Halestrap, A. P. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c130008 · Cited by 339
Gui, D. Y., Sullivan, L. B., Luengo, A., Hosios, A. M., Bush, L. N., Gitego, N., Davidson, S. M., Freinkman, E., Thomas, C. J., & Vander Heiden, M. G. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.006 · Cited by 323 · cited 1×
“The antidiabetic drug metformin is known to alter cellular metabolism through mitochondrial OXPHOS complex I inhibition [76] [77] [78] [79] [80].”
BackgroundValencia, T., Kim, J. Y., Abu-Baker, S., Moscat-Pardos, J., Ahn, C. S., Reina-Campos, M., Duran, A., Castilla, E. A., Metallo, C. M., Diaz-Meco, M. T., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.004 · Cited by 304
Repurposing metformin for the prevention of cancer and cancer recurrence
Heckman-Stoddard, B. M., DeCensi, A., Sahasrabuddhe, V. V., & Ford, L. G. (2017) · Diabetologia · doi:10.1007/s00125-017-4372-6 · Cited by 297
Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Flomenberg, N., Birbe, R., Witkiewicz, A. K., Howell, A., Pavlides, S., Tsirigos, A., Ertel, A., Pestell, R. G., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18151 · Cited by 292
Self-citationWitkiewicz, A. K., Dasgupta, A., Sotgia, F., Mercier, I., Pestell, R. G., Sabel, M., Kleer, C. G., Brody, J. R., & Lisanti, M. P. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080873 · Cited by 283
Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Sotgia, F., Martinez-Outschoorn, U. E., Howell, A., Pestell, R. G., Pavlides, S., & Lisanti, M. P. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120856 · Cited by 281
Self-citationZhang, X., Fryknäs, M., Hernlund, E., Fayad, W., De Milito, A., Olofsson, M. H., Gogvadze, V., Dang, L., Påhlman, S., Schughart, L. A. K., et al. (2014) · Nature Communications · doi:10.1038/ncomms4295 · Cited by 253
Martinez-Outschoorn, U. E., Pavlides, S., Whitaker-Menezes, D., Daumer, K. M., Milliman, J. N., Chiavarina, B., Migneco, G., Witkiewicz, A. K., Martinez-Cantarin, M. P., Flomenberg, N., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.12.12048 · Cited by 246
Self-citationWitkiewicz, A. K., Whitaker-Menezes, D., Dasgupta, A., Philp, N. J., Lin, Z., Gandara, R., Sneddon, S., Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19530 · Cited by 239
Self-citationMetformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Liu, X., Romero, I. L., Litchfield, L. M., Lengyel, E., & Locasale, J. W. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.005 · Cited by 236
Curry, J. M., Tuluc, M., Whitaker-Menezes, D., Ames, J. A., Anantharaman, A., Butera, A., Leiby, B., Cognetti, D., Sotgia, F., Lisanti, M. P., et al. (2013) · Cell Cycle · doi:10.4161/cc.24092 · Cited by 235
Self-citationMCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4
Hong, C. S., Graham, N. A., Gu, W., Espindola Camacho, C., Mah, V., Maresh, E. L., Alavi, M., Bagryanova, L., Krotee, P. A. L., Gardner, B. K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.057 · Cited by 226
Bonuccelli, G., Whitaker-Menezes, D., Castello-Cros, R., Pavlides, S., Pestell, R. G., Fatatis, A., Witkiewicz, A. K., Vander Heiden, M. G., Migneco, G., Chiavarina, B., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.10.11601 · Cited by 220
Self-citationCancer metabolism in space and time: Beyond the Warburg effect
Danhier, P., Bański, P., Payen, V. L., Grasso, D., Ippolito, L., Sonveaux, P., & Porporato, P. E. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.001 · Cited by 214
Caveolae and signalling in cancer
Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3915 · Cited by 211
Self-citationBola, B. M., Chadwick, A. L., Michopoulos, F., Blount, K. G., Telfer, B. A., Williams, K. J., Smith, P. D., Critchlow, S. E., & Stratford, I. J. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1091 · Cited by 203
Palmer, L. A., Gaston, B., & Johns, R. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12688-0 · Cited by 193
Wurm, C. A., Neumann, D., Lauterbach, M. A., Harke, B., Egner, A., Hell, S. W., & Jakobs, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107553108 · Cited by 173 · cited 1×
“TOMM20 (translocase of outer mitochondrial membrane 20) is the receptor subunit of the mitochondrial membrane import pore, which allows the import of nuclear encoded OXPHOS subunits and induces OXPHOS [22].”
BackgroundKo, Y.-H., Lin, Z., Flomenberg, N., Pestell, R. G., Howell, A., Sotgia, F., Lisanti, M. P., & Martinez-Outschoorn, U. E. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.12.18671 · Cited by 173
Self-citationHepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress
Huang, D., Li, T., Wang, L., Zhang, L., Yan, R., Li, K., Xing, S., Wu, G., Hu, L., Jia, W., et al. (2016) · Cell Research · doi:10.1038/cr.2016.109 · Cited by 170
Cancer’s Fuel Choice: New Flavors for a Picky Eater
DeNicola, G. M., & Cantley, L. C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.018 · Cited by 165
Altered Mitochondrial Function and Metabolic Inflexibility Associated with Loss of Caveolin-1
Asterholm, I. W., Mundy, D. I., Weng, J., Anderson, R. G. W., & Scherer, P. E. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.004 · Cited by 163
Wanka, C., Steinbach, J. P., & Rieger, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384578 · Cited by 162
Sonnenblick, A., Agbor-Tarh, D., Bradbury, I., Di Cosimo, S., Azim, H. A., Fumagalli, D., Sarp, S., Wolff, A. C., Andersson, M., Kroep, J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.7722 · Cited by 160
Pasupathy, S., Tavella, R., Grover, S., Raman, B., Procter, N. E. K., Du, Y., Mahadavan, G., Stafford, I., Heresztyn, T., Holmes, A. S., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027575 · Cited by 160
Incio, J., Suboj, P., Chin, S. M., Vardam-Kaur, T., Liu, H., Hato, T., Babykutty, S., Chen, I. X., Deshpande, V., Jain, R. K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141392 · Cited by 153
Huang, C.-K., Chang, P.-H., Kuo, W., Chen, C., Jeng, Y., Chang, K., Shew, J.-Y., Hu, C.-M., & Lee, W. (2017) · Nature Communications · doi:10.1038/ncomms14706 · Cited by 139
N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects
Minarini, A., Ferrari, S., Galletti, M., Giambalvo, N., Perrone, D., Rioli, G., & Galeazzi, G. M. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1251580 · Cited by 137
Diers, A. R., Broniowska, K. A., Chang, C.-F., & Hogg, N. (2012) · Biochemical Journal · doi:10.1042/bj20120294 · Cited by 133
Ayala, G., Morello, M., Frolov, A., You, S., Li, R., Rosati, F., Bartolucci, G., Danza, G., Adam, R. M., Thompson, T. C., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4217 · Cited by 125
Kim, Y., Choi, J.-W., Lee, J. H., & Kim, Y.-S. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.09.013 · Cited by 123
Pértega‐Gomes, N., Vizcaino, J. R., Attig, J., Jurmeister, S., Lopes, C., & Baltazar, F. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-352 · Cited by 119
Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer
Won, K. Y., Lim, S., Kim, G. Y., Kim, Y. W., Han, S., Song, J. Y., & Lee, D. K. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.04.021 · Cited by 114
Increased Oxidative Metabolism in the Li–Fraumeni Syndrome
Wang, P.-Y., Ma, W., Park, J.-Y., Celi, F. S., Arena, R., Choi, J. W., Ali, Q. A., Tripodi, D. J., Zhuang, J., Lago, C. U., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214091 · Cited by 114
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
Bovenzi, C. D., Hamilton, J., Tassone, P. T., Johnson, J. M., Cognetti, D. M., Luginbuhl, A., Keane, W. M., Zhan, T., Tuluc, M., Bar‐Ad, V., et al. (2015) · BioMed Research International · doi:10.1155/2015/242437 · Cited by 103
Self-citationThe metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4
Pinheiro, C. M., Miranda‐Gonçalves, V., Longatto‐Filho, A., Vicente, A. L. S. A., Berardinelli, G. N., Scapulatempo‐Neto, C., Costa, R. F. A., Viana, C. R., Reis, R. M., Baltazar, F., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1175258 · Cited by 100
Wu, D., Zhuo, L., & Wang, X. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.11.003 · Cited by 92
Chiavarina, B., Martinez‐Outschoorn, U., Whitaker‐Menezes, D., Howell, A., Tanowitz, H. B., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.21643 · Cited by 90
Self-citationGoodwin, M. L., Jin, H., Straessler, K. M., Smith-Fry, K., Zhu, J.-F., Monument, M. J., Grossmann, A. H., Randall, R. L., Capecchi, M. R., & Jones, K. B. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.003 · Cited by 87
Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
Eilertsen, M., Andersen, S., Al‐Saad, S., Kiselev, Y., Dønnem, T., Stenvold, H., Pettersen, I., Al-Shibli, K. I., Richardsen, E. H., Busund, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105038 · Cited by 87
Ko, Y., Domingo‐Vidal, M., Roche, M. E., Lin, Z., Whitaker‐Menezes, D., Seifert, E. L., Capparelli, C., Tuluc, M., Birbe, R., Tassone, P. T., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.740209 · Cited by 83
Self-citationOutcomes from massive paracetamol overdose: a retrospective observational study
Marks, D. J., Dargan, P. I., Archer, J. R. H., Davies, C. L., Dines, A. M., Wood, D. M., & Greene, S. L. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13214 · Cited by 80
Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival
Wu, K., Queenan, M., Brody, J. R., Potoczek, M., Sotgia, F., Lisanti, M. P., & Witkiewicz, A. K. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18551 · Cited by 76
Caveolin-1 Expression Level in Cancer Associated Fibroblasts Predicts Outcome in Gastric Cancer
Zhao, X., He, Y., Gao, J., Fan, L., Li, Z., Yang, G., & Chen, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059102 · Cited by 75
Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
Curry, J., Johnson, J. M., Tassone, P. T., Domingo‐Vidal, M., Menezes, D. W., Sprandio, J. D., Mollaee, M., Cotzia, P., Birbe, R., Lin, Z., et al. (2017) · The Laryngoscope · doi:10.1002/lary.26489 · Cited by 74
Self-citationMCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis
Lee, J. Y., Lee, I., Chang, W. J., Ahn, S. M., Kim, H. S., Kim, H. S., Yoo, K. H., Jung, K. S., Song, H., Cho, J. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9523 · Cited by 70
MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer
Johnson, J. M., Cotzia, P., Fratamico, R., Mikkilineni, L., Chen, J., Colombo, D., Mollaee, M., Whitaker‐Menezes, D., Domingo‐Vidal, M., Lin, Z., et al. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00027 · Cited by 68
Self-citationde Oliveira, A. T. T., Pinheiro, C. M., Longatto‐Filho, A., Brito, M. J., Martinho, O., Matos, D., Carvalho, A. L., Vazquez, V. D. L., Silva, T. B., Scapulatempo‐Neto, C., et al. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9408-5 · Cited by 65
Zhao, Z., Han, F., He, Y., Yang, S., Hua, L., Wu, J., & Zhan, W. (2014) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2014.04.005 · Cited by 62
Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer
Johnson, J. M., Lai, S. Y., Cotzia, P., Cognetti, D. M., Luginbuhl, A., Pribitkin, E. A., Zhan, T., Mollaee, M., Domingo‐Vidal, M., Chen, Y., et al. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.025 · Cited by 55
Self-citationFowdar, K., Chen, H., He, Z., Zhang, J., Zhong, X.-N., Zhang, J., Li, M., & Bai, J. (2017) · Heart & Lung · doi:10.1016/j.hrtlng.2016.12.004 · Cited by 55
Qian, S., Li, J., Hong, M., Zhu, Y., Zhao, H., Xie, Y., Huang, J., Lian, Y., Li, Y., Wang, S., et al. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0360-4 · Cited by 54
Prognostic significance of monocarboxylate transporter expression in oral cavity tumors
Simoes‐Sousa, S., Granja, S., Pinheiro, C. M., Fernandes, D., Longatto‐Filho, A., Laus, A. C., Alves, C. D. C., Peñaranda, J. M. S., Pérez‐Sayáns, M., Carvalho, A. L., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1188239 · Cited by 50
Gerin, I., Noël, G., Bolsée, J., Haumont, O., SCHAFTINGEN, E. V., & Bommer, G. T. (2014) · Biochemical Journal · doi:10.1042/bj20130841 · Cited by 49
Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival
Zhao, Z. Q., Han, F., Yang, S., Hua, L., Wu, J.-H., & Zhan, W. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i4.1140 · Cited by 47
Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors
Pinheiro, C. M., Granja, S., Longatto‐Filho, A., Faria, A. M., Fragoso, M. C. B. V., Lovisolo, S. M., Lerário, A. M., Almeida, M. Q., Baltazar, F., & Zerbini, M. C. N. (2015) · Oncotarget · doi:10.18632/oncotarget.5623 · Cited by 44
Pinheiro, C. M., Penna, V., Morais-Santos, F., Abrahão‐Machado, L. F., Ribeiro, G., Curcelli, E. M., Olivieri, M. V., Morini, S., Valença, I., Ribeiro, D., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-118 · Cited by 42
Afonso, J., Santos, L. L., Morais, A., Amaro, T., Longatto‐Filho, A., & Baltazar, F. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1121329 · Cited by 40
Andersen, S., Solstad, Ø. B., Moi, L. L. H., Dønnem, T., Eilertsen, M., Nordby, Y., Ness, N., Richardsen, E. H., Busund, L., & Bremnes, R. M. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.05.013 · Cited by 37
Rico-Bautista, E., Zhu, W., Kitada, S., Ganapathy, S., Lau, E. K., Krajewski, S., Ramirez, J., Bush, J., Yuan, Z.-M., & Wolf, D. A. (2013) · Oncotarget · doi:10.18632/oncotarget.1130 · Cited by 35
Zhou, X., Xie, W., Li, Q., Zhang, Y., Zhang, J., Zhao, X., Liu, J., & Huang, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080576 · Cited by 22
Bradley, C. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.37 · Cited by 11
Cited by
Wang, B., Wang, Y., Zhang, J., Hu, C., Jiang, J., Li, Y., & Peng, Z. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03476-6 · Cited by 858
Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Schiliro, C., & Firestein, B. L. (2021) · Cells · doi:10.3390/cells10051056 · Cited by 615
NF-κB: blending metabolism, immunity, and inflammation
Capece, D., Verzella, D., Flati, I., Arboretto, P., Cornice, J., & Franzoso, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.07.004 · Cited by 538
Lactate in the tumour microenvironment: From immune modulation to therapy
Wang, Z.-H., Peng, W.-B., Zhang, P., Yang, X.-P., & Zhou, Q. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103627 · Cited by 528
Erin, N., Grahovac, J., Brozovic, A., & Efferth, T. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100715 · Cited by 527
Metadata
- Authors
- Wilde, L., Roche, M., Domingo-Vidal, M., Tanson, K., Philp, N., Curry, J., & Martinez-Outschoorn, U.
- Venue
- Seminars in Oncology
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 44
- Issue
- 3
- Pages
- 198-203
- ISSN
- 0093-7754 (ISSN-L)
- OpenAlex
- W2763966161
- Cited by
- 326
- References
- 106
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.